NCT04426708View on ClinicalTrials.gov

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

July 3, 2020

Study Completion Date

July 3, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

HMS5552

single dose of HMS5552 25mg

Trial Locations (1)

610000

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT04426708 - A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers | Biotech Hunter | Biotech Hunter